Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Discovery of back-up HNE inhibitors detailed by GSK

Sep. 18, 2002

Selective NK1 antagonist derived from dual NK1/NK2 antagonist at AstraZeneca

Sep. 17, 2002

Inhibitors of IL-4 production with potential in asthma, allergy and other disorders

Sep. 17, 2002

Potent, well-tolerated PDE4 inhibitor with suitable PK profile selected for development at Merck

Sep. 13, 2002

Novel CCR1 antagonists and their use in asthma and other disorders

Sep. 12, 2002

FDA advisory committee recommends approval of Spiriva

Sep. 10, 2002

New PDE4 inhibitors prepared and tested at Mercian

Sep. 10, 2002

Potential new treatments for chronic bronchitis targeting 15-LO sought by Pfizer

Sep. 10, 2002

Syk inhibitors synthesized at Novartis as novel therapeutics for asthma

Sep. 10, 2002

Orally active B-cell IgE synthesis inhibitors discovered by Novartis team

Sep. 10, 2002

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...